Acrivon Therapeutics
Clinical trials sponsored by Acrivon Therapeutics, explained in plain language.
-
First patients to test new cancer pill in groundbreaking safety trial
Disease control Recruiting nowThis is the first study in people to test a new oral drug called ACR-2316 for treating advanced solid tumors. It aims to find a safe and tolerable dose for patients whose cancer has progressed after prior treatments. The study will enroll about 100 people to closely monitor how t…
Phase: PHASE1 • Sponsor: Acrivon Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Personalized cancer drug trial seeks to control advanced uterine cancer
Disease control Recruiting nowThis study is testing whether the drug ACR-368 can help control advanced endometrial cancer that has progressed after previous treatments. The trial will enroll 353 participants and uses a personalized approach: some patients receive ACR-368 alone while others receive it with a l…
Phase: PHASE2 • Sponsor: Acrivon Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC